Difficult to believe that BOT is the only play progressing clinical trials for derma based CBD applications........"Only 1 trial in dermatology(Botanix)"
"Botanix holds the exclusive rights to utilise Permetrex for all drugs that treat skin diseases".........."Permetrex™ technology enables superior delivery of cannabidiol"........
Seriously looking forward to seeing these trial results........and very much awaiting some positive news re the possible functionality of the antimicrobial BTX1801....
Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-3
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |